1. Home
  2. KIM vs ALGN Comparison

KIM vs ALGN Comparison

Compare KIM & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIM
  • ALGN
  • Stock Information
  • Founded
  • KIM 1958
  • ALGN 1997
  • Country
  • KIM United States
  • ALGN United States
  • Employees
  • KIM N/A
  • ALGN N/A
  • Industry
  • KIM Real Estate Investment Trusts
  • ALGN Industrial Specialties
  • Sector
  • KIM Real Estate
  • ALGN Health Care
  • Exchange
  • KIM Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • KIM 16.9B
  • ALGN 16.5B
  • IPO Year
  • KIM 1991
  • ALGN N/A
  • Fundamental
  • Price
  • KIM $23.28
  • ALGN $212.69
  • Analyst Decision
  • KIM Buy
  • ALGN Hold
  • Analyst Count
  • KIM 16
  • ALGN 10
  • Target Price
  • KIM $24.53
  • ALGN $268.56
  • AVG Volume (30 Days)
  • KIM 3.7M
  • ALGN 677.8K
  • Earning Date
  • KIM 02-06-2025
  • ALGN 01-29-2025
  • Dividend Yield
  • KIM 4.23%
  • ALGN N/A
  • EPS Growth
  • KIM N/A
  • ALGN 24.62
  • EPS
  • KIM 0.53
  • ALGN 5.86
  • Revenue
  • KIM $1,963,220,000.00
  • ALGN $3,960,519,000.00
  • Revenue This Year
  • KIM N/A
  • ALGN $5.72
  • Revenue Next Year
  • KIM $3.40
  • ALGN $6.12
  • P/E Ratio
  • KIM $44.68
  • ALGN $36.27
  • Revenue Growth
  • KIM 10.81
  • ALGN 4.03
  • 52 Week Low
  • KIM $17.57
  • ALGN $196.09
  • 52 Week High
  • KIM $25.83
  • ALGN $335.40
  • Technical
  • Relative Strength Index (RSI)
  • KIM 27.53
  • ALGN 36.43
  • Support Level
  • KIM $24.34
  • ALGN $226.67
  • Resistance Level
  • KIM $25.06
  • ALGN $246.19
  • Average True Range (ATR)
  • KIM 0.42
  • ALGN 7.69
  • MACD
  • KIM -0.21
  • ALGN -1.91
  • Stochastic Oscillator
  • KIM 0.39
  • ALGN 0.56

About KIM Kimco Realty Corporation (HC)

One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 569 shopping centers throughout major markets in the US, representing roughly 87 million square feet.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: